Resources

This spreadsheet provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention.Sources of information for these trials are clinicaltrials.gov; who.int/clinical-trials-registry-platform; clinicaltrialsregister.eu; and anzctr.org.au, which includes clinical trial registries from 17 countries.Some information is also obtained through contact with investigators, sponsors, and funders of vaccine trials. This spreadsheet pairs with the RSV Vaccine and mAb Snapshot, which provides a summary of the RSV vaccine and mAb candidates in development worldwide.

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International annual general meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

On 14 October, 2024, PATH co-hosted a forum to begin the conversation on financing the remaining gaps in access to medical oxygen. The event highlighted the critical role of sustained financing and donor commitments, following the launch of the oxygen investment case commissioned by the Global Oxygen Alliance (GO2AL) and the Lancet Global Health Commission Report on Oxygen Access—and ahead of upcoming funding rounds from international donors.

This high-level webinar was part of the VacciNations Campaign, bringing together policymakers, technical teams, key decision-makers and civil society organizations from the African region and beyond.It focused on immunization financing and accountability, and what is needed to ramp up efforts towards the 2030 Sustainable Development Goals (SDG) 3 targets. The presentations included findings from recent studies on immunization financing, and identified strategies to improve funding and accountability mechanisms to achieve the 2030 SDG 3 targets.

Many countries struggle to provide high-quality primary health care and achieve universal health coverage because of a shortage of trained clinicians. Consequently, citizens experience a variable standard of care depending on the level of training and experience of the health care workers in their community. Appropriate and user-friendly tools are needed that can provide on-demand, expert-level information and support to frontline health care workers to standardize care and treat more patients effectively.Can artificial intelligence-assisted tools support better primary health care delivery? Artificial intelligence (AI)-based tools are increasingly being used to assist health care workers with diagnosis and treatment. These include large language model (LLM)-enabled tools that can provide expert-level medical knowledge and advice in response to health care workers’ queries. Because LLMs have the ability to be trained to think like a local medical expert, continuously learn, and provide responses to a wide range of queries, this technology is seen to have the potential to enhance clinical decision support systems (CDSSs) and improve the quality of primary health care.